语言版本

Time of issue:2021-09-02 16:56:33
搜索
Search
/
/
/
Olopatadine HCl
All categories
Number of views:
1000

Olopatadine HCl

Olopatadine HCl was developed by Kyowa Hakko Kirin, and it was first approved by the FOOD and Drug Administration (FDA) of the United States on December 18, 1996,
Retail price
0.0
Market price
0.0
Number of views:
1000
No.
Category
API
Chemical Name:
11-(Z)-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-acetic acid, hydrochloride
Molecular Formula:
C21H23O3N·HCl
Molecular Weight:
373.88
Therapeutic Classification:
Antihistamine
CAS:
140462-76-6
Registration File:
US-DMF, JDMF, etc.
Quantity
-
+
Stock:
Detail
Parameters

  Olopatadine HCl was developed by Kyowa Hakko Kirin, and it was first approved by the FOOD and Drug Administration (FDA) of the United States on December 18, 1996, and later approved by the Japanese Pharmaceutical and Medical Device Comprehensive Organization (PMDA) on December 22, 2000. It was approved for marketing by the European Medicines Agency (EMA) on 17 May 2002. It is sold in the United States by Alcon with the name Patanol. Olopatadine HCl is an antihistamine (an anticholinergic medicine and mast cell stabilizers), which is suitable for the treatment of allergic conjunctivitis. Patanol is an eye drop containing 0.1% olopatadine. The recommended dose is 1 drop to the affected eye twice a day with an interval of 6-8 hours.

Keyword:
Olopatadine
Patanol
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
Next

RELATED WEBSITES

友情链接

Time of issue:2020-07-27 00:00:00
Online customer service
Customer service hotline
+86-023-67886928 +86-023-67886928
Service time:
8:30 - 17:30
Customer service group:
在线客服

地址版权

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved.  渝ICP备2021007919号  1渝公网安备50011702500758号  Powered by:www.300.cn

地址版权手机

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd.

渝ICP备2021007919号  Powered by:www.300.cn

1渝公网安备50011702500758号